Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curosurf vs Survanta in Very Premature Infants With RDS
NCT00767039Phase 4Terminated
- Start
- Jan 2005
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Poractant alfa in respiratory distress syndrome (RDS). Started Jan 2005; status: terminated.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT00767039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767039.